Investors subscription thank you

Contact us
International Headquarters
Adverse reactions - Pharmacovigilance
Grifols Ethics Line

Change Language
Español
Deutsch
中文

Company

Since 1909, Grifols has worked to improve the health and well-being of people around the world.

Read more
- Corporate Structure
  
  Board of Directors
  
  Management Team
- What We Do
  
  Biopharma
  
  Diagnostic
  
  Bio Supplies
  
  Healthcare Solutions for Hospitals
- Grifology
  
  The Cabinet
- Grifols Engineering
Every action we take is motivated by our mission to improve people's lives.

Our unique and remarkable history combines scientiﬁc expertise with a desire to serve patients and society.

We develop, produce and market innovative medicines, solutions and services in more than 110 countries.
Innovation

Grifols is full speed ahead on developing the next innovative breakthroughs across multiple therapeutic areas.

Read more
- CHRONOS-PD: Plasma Science in Parkinson’s Research
- Extending Our Innovative Reach
  
  Team Up with Grifols Innovation and New Technologies
  
  Scientific Awards and Programs
- Connecting Knowledge - Our R&D Network
We apply our growing knowledge of plasma to change healthcare.

Our treatments are enhancing people’s well-being and quality of life.

We’re drawing on a broad scientific base to continue innovating.
Sustainability

Grifols' longstanding commitment to people and the planet entails helping society on all fronts.

Read more
- The Environment
- Ethical Leadership
- Sustainability Reports
2024 Integrated and Sustainability Annual Report

Patients drive the work we do every day. We support patients and patient associations.

As mindful stewards of the environment we are resolved to fight climate change.
Products
Investors

Read more
- Stock Information
  
  Stock and share capital
  
  Dividends
  
  Major Holders and Treasury Stock
  
  Agreements between Shareholders
  
  Analyst Coverage
- Financials
  
  Financial Results
  
  Annual Accounts
  
  Fixed Income and Credit Ratings
  
  Average Period of Payment to Suppliers
  
  Key Figures
- Press Releases
- Presentations and Events
- Agenda
- Communications with CNMV and SEC
  
  CNMV
  
  SEC
  
  Other Relevant Information
  
  Inside Information
  
  Significant events until 8 February 2020
- Corporate Stewardship Reports
Presentation Second Quarter 2025 Results

2024 Integrated and Sustainability Annual Report

2025 Investor and Analyst meeting - webcast
Careers

People are at the heart of our business. We are committed to continued investment in training and development.

Explore Opportunities
- Why Grifols
  
  People & Culture
  
  Our teams
Media

Latest news about the company and contact information for journalists and communication professionals.

Read more
- Newsroom
- Events
  
  H1 2025 Financial Results
  
  General Shareholders' Meeting 2025
- Media Contacts
- Media Center
Partners

At Grifols, we believe in long-term, mutually trusting relationships with our partners.

More details
- Join our network of suppliers

Change Language
Español
Deutsch
中文

Company
Innovation
Sustainability
Products
Investors
Careers
Media
Partners
- Partners
- Join our network of suppliers

Connect with us

Your request for subscribing to Grifols investor alerts has been registered correctly.

Back to Investors page

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed as, promoting any products in countries in which they are not approved.

About Us

Company
Sustainability
Innovation
Products
Investors
Careers
Media

Top websites

Grifols Plasma
Grifols Diagnostics Solutions
Grifols Scientific Awards
Grifols Engineering
Grifols Egypt for Plasma Derivatives
Victor Grifols i Lucas Foundation
Probitas Foundation
J.A. Grifols Foundation

Legal & Help

Privacy Notices
Cookies Policy
Cookies Settings
Terms of Use
Contact
Glossary

Connect with us

© 2025 Grifols, S.A. All rights reserved worldwide.

You're now in
Reduced Motion Mode

You can change back to motion enhanced mode at the top of the page.